FZ-AD005

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameFZ-AD005

Drug Alias NameFZ-AD005FZAD005F0041

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionAnti-Delta-like protein 3DNA topoisomerase I inhibitors

TargetsDelta-like protein 3DNA topoisomerase I

Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Neuroendocrine +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Neuroendocrine +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A